Search Site
Home » Blogs » Recommendation Updates » Bristol-Myers Squibb Began Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
Large Cap / Pharmaceuticals, Biotechnology & Life Sciences
BMY Commences Tender Offer to Purchase All Outstanding Shares of AMLN

Bristol-Myers Squibb Began Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

July 10, 2012
KEYWORDS Bristol-Myers Squibb / Bristol-Myers / BMY / Bristol Myers Squibb / Bristol-Myers Management / Bristol-Myers Executives / Bristol / Bristol-Myers Squibb Company / Bristol-Myers Squibb acquisition / Bristol-Myers Acquisition / Bristol-Myers purchase / Bristol Myers Squibb Company / AMLN / Amylin
 / Print / Reprints /
| Share More
/ Text Size+
Larger Smaller
[X]

On July 10, 2012, Bristol-Myers Squibb Company (NYSE: BMY) commenced a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.

To view the full article, please subscribe or login.

Profit from The Turnaround Letter's...

  • Market-Beating Investment Results
  • 25+ Years of Turnaround Experience
  • Diverse Stock Picks for Today's Unpredictable Market

TLCorner

Time to Pay the Piper: 7 Strategies to Minimize Tax Pain

“No taxes can be devised which are not more or less inconvenient and unpleasant.” ~ George Washington Read More.

Europe’s Not Out of the Woods Yet, But…

The latest banking crisis in Europe, this time in the tiny island nation of Cyprus, shows that the continent has not yet truly solved its financial problems. It has only applied a series of band-aids that have temporarily averted disaster, but have not yet provided a firmer long-term footing for the Euro-bloc. There could be another crisis of confidence at almost any time, with Italy and Spain being the most likely instigators. Read More.

What did The Turnaround Letter see that others did not?

What did The Turnaround Letter see in these companies that others did not?

Questions & Tips

AskGeorge

Why are you still recommending MGIC?

I don’t normally comment on individual stocks in this particular blog, but the MGIC situation represents a basic investment principle that is worthy of discussion here.

Read More.

How important are Price-to-Earnings (P/E) ratios in evaluating turnaround stocks?

Price-to-Earnings ratios are probably the most widely used tool for comparing the relative values of different stocks.

Read More.

Does the poor performance of the stock market in May indicate that the U.S. is headed for a new recession?

This question comes up frequently when the market takes a dip.

Read More.

Barron's Proclaims:

"For 21 years, George Putnam III has trained his sights on one of the more obscure areas of investing: turnaround situations and bankruptcies. By focusing on out-of-favor companies, his flagship publication, The Turnaround Letter, has achieved enormous success for its subscribers."

 

MOSTPOPULAR

Purchase Recommendation - June 2013

Major Oil Stocks: Low Valuations & High Yields

Data Storage Stocks: Repositories of Value & Opportunity?

Sale Recommendations - June 2013

Updates for June 2013: Purchase Price Raised for Interpublic, Boston Scientific, Ford, Marsh & Fifth Third